Advanced search
Publication Cover
Infectious Diseases Volume 56, 2024 - Issue 6
Submit an article Journal homepage
566
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Double-blinded, randomised, placebo-controlled trial of convalescent plasma for COVID-19: analyses by neutralising antibodies homologous to recipients’ variants

T. Khawajaa Meilahti Vaccine Research Center, MeVac, Department of Infectious Diseases, University of Helsinki and Helsinki University Hospital, Helsinki, Finland;b Department of Infectious Diseases, University of Helsinki and Helsinki University Hospital, Helsinki, Finland;c Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland;d FIMAR, Multidisciplinary Center of Excellence in Antimicrobial Resistance Research, University of Helsinki, Helsinki, FinlandView further author information
,
M. Kajovaa Meilahti Vaccine Research Center, MeVac, Department of Infectious Diseases, University of Helsinki and Helsinki University Hospital, Helsinki, Finland;b Department of Infectious Diseases, University of Helsinki and Helsinki University Hospital, Helsinki, Finland;c Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland;d FIMAR, Multidisciplinary Center of Excellence in Antimicrobial Resistance Research, University of Helsinki, Helsinki, FinlandView further author information
,
I. Levonena Meilahti Vaccine Research Center, MeVac, Department of Infectious Diseases, University of Helsinki and Helsinki University Hospital, Helsinki, Finland;c Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, FinlandView further author information
,
J. P. Pietiläa Meilahti Vaccine Research Center, MeVac, Department of Infectious Diseases, University of Helsinki and Helsinki University Hospital, Helsinki, Finland;c Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland;d FIMAR, Multidisciplinary Center of Excellence in Antimicrobial Resistance Research, University of Helsinki, Helsinki, FinlandView further author information
,
H. Välimaaa Meilahti Vaccine Research Center, MeVac, Department of Infectious Diseases, University of Helsinki and Helsinki University Hospital, Helsinki, Finland;e Department of Virology, University of Helsinki, Helsinki, FinlandView further author information
,
J. Paajanena Meilahti Vaccine Research Center, MeVac, Department of Infectious Diseases, University of Helsinki and Helsinki University Hospital, Helsinki, Finland;f Department of Pulmonary Medicine, Heart and Lung Center, University of Helsinki and Helsinki University Hospital, Helsinki, FinlandView further author information
,
S. H. Pakkanena Meilahti Vaccine Research Center, MeVac, Department of Infectious Diseases, University of Helsinki and Helsinki University Hospital, Helsinki, Finland;c Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland;d FIMAR, Multidisciplinary Center of Excellence in Antimicrobial Resistance Research, University of Helsinki, Helsinki, FinlandView further author information
,
A. Patjasa Meilahti Vaccine Research Center, MeVac, Department of Infectious Diseases, University of Helsinki and Helsinki University Hospital, Helsinki, Finland;c Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland;d FIMAR, Multidisciplinary Center of Excellence in Antimicrobial Resistance Research, University of Helsinki, Helsinki, FinlandView further author information
,
R. Montonene Department of Virology, University of Helsinki, Helsinki, FinlandView further author information
,
S. Miettinene Department of Virology, University of Helsinki, Helsinki, Finland;g Department of Veterinary Biosciences, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, FinlandView further author information
,
J. Virtanene Department of Virology, University of Helsinki, Helsinki, Finland;g Department of Veterinary Biosciences, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, FinlandView further author information
,
T. Smurae Department of Virology, University of Helsinki, Helsinki, FinlandView further author information
,
T. Sironene Department of Virology, University of Helsinki, Helsinki, Finland;g Department of Veterinary Biosciences, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, FinlandView further author information
,
R. Fagerlunde Department of Virology, University of Helsinki, Helsinki, FinlandView further author information
,
H. Ugurlue Department of Virology, University of Helsinki, Helsinki, FinlandView further author information
,
R. Iheozor-Ejiofore Department of Virology, University of Helsinki, Helsinki, Finland;g Department of Veterinary Biosciences, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, FinlandView further author information
,
K. Sakselae Department of Virology, University of Helsinki, Helsinki, Finland;h HUS Diagnostic Centre, HUSLAB, Clinical Microbiology, Helsinki University Hospital, Helsinki, FinlandView further author information
,
T. Vahlbergi Department of Biostatistics, University of Turku and Turku University Hospital, Turku, FinlandView further author information
,
A. Rankij Department of Dermatology, Allergology and Venereology, University of Helsinki and Helsinki University Hospital, Helsinki, FinlandView further author information
,
A. Vierikkok Finnish Red Cross Blood Service, Helsinki, FinlandView further author information
,
J. Ihalainenk Finnish Red Cross Blood Service, Helsinki, FinlandView further author information
,
O. Vapalahtie Department of Virology, University of Helsinki, Helsinki, Finland;g Department of Veterinary Biosciences, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland;h HUS Diagnostic Centre, HUSLAB, Clinical Microbiology, Helsinki University Hospital, Helsinki, FinlandView further author information
&
A. Kantelea Meilahti Vaccine Research Center, MeVac, Department of Infectious Diseases, University of Helsinki and Helsinki University Hospital, Helsinki, Finland;b Department of Infectious Diseases, University of Helsinki and Helsinki University Hospital, Helsinki, Finland;c Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland;d FIMAR, Multidisciplinary Center of Excellence in Antimicrobial Resistance Research, University of Helsinki, Helsinki, FinlandCorrespondence[email protected]
View further author information
 show all
Pages 423-433 | Received 18 Dec 2023, Accepted 08 Mar 2024, Published online: 21 Mar 2024

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.